vs

Side-by-side financial comparison of REPLIGEN CORP (RGEN) and BOSTON BEER CO INC (SAM). Click either name above to swap in a different company.

BOSTON BEER CO INC is the larger business by last-quarter revenue ($461.6M vs $197.9M, roughly 2.3× REPLIGEN CORP). On growth, REPLIGEN CORP posted the faster year-over-year revenue change (13.6% vs -4.1%). Over the past eight quarters, REPLIGEN CORP's revenue compounded faster (14.4% CAGR vs -10.7%).

Repligen Corporation is a global life sciences company devoted to the development and commercialization of innovative bioprocessing technologies and systems that enable efficiencies in the process of manufacturing biological drugs.2025 The company is based in Waltham, Massachusetts,2014 and was incorporated in Delaware in 1981. A public company, Repligen is listed on the NASDAQ exchange under the symbol RGEN. As of 2025, Repligen employs over 1,900 employees globally and serves primarily biop...

The Boston Beer Company is an American brewery founded in 1984 by James "Jim" Koch and Rhonda Kallman. Boston Beer Company's first brand of beer was named Samuel Adams after Founding Father Samuel Adams, an American revolutionary patriot. Since its founding, Boston Beer has started several other brands, and in 2019 completed a merger with Dogfish Head Brewery.

RGEN vs SAM — Head-to-Head

Bigger by revenue
SAM
SAM
2.3× larger
SAM
$461.6M
$197.9M
RGEN
Growing faster (revenue YoY)
RGEN
RGEN
+17.8% gap
RGEN
13.6%
-4.1%
SAM
Faster 2-yr revenue CAGR
RGEN
RGEN
Annualised
RGEN
14.4%
-10.7%
SAM

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
RGEN
RGEN
SAM
SAM
Revenue
$197.9M
$461.6M
Net Profit
$13.3M
Gross Margin
52.5%
46.4%
Operating Margin
9.0%
12.4%
Net Margin
6.7%
Revenue YoY
13.6%
-4.1%
Net Profit YoY
143.9%
EPS (diluted)
$0.24
$2.16

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
RGEN
RGEN
SAM
SAM
Q1 26
$461.6M
Q4 25
$197.9M
$385.7M
Q3 25
$188.8M
$537.5M
Q2 25
$182.4M
$587.9M
Q1 25
$169.2M
$453.9M
Q4 24
$174.1M
$402.3M
Q3 24
$154.9M
$605.5M
Q2 24
$154.1M
$579.1M
Net Profit
RGEN
RGEN
SAM
SAM
Q1 26
Q4 25
$13.3M
$-22.5M
Q3 25
$14.9M
$46.2M
Q2 25
$14.9M
$60.4M
Q1 25
$5.8M
$24.4M
Q4 24
$-30.3M
$-38.8M
Q3 24
$-654.0K
$33.5M
Q2 24
$3.3M
$52.3M
Gross Margin
RGEN
RGEN
SAM
SAM
Q1 26
46.4%
Q4 25
52.5%
43.5%
Q3 25
53.2%
50.8%
Q2 25
50.0%
49.8%
Q1 25
53.6%
48.3%
Q4 24
26.1%
39.9%
Q3 24
50.0%
46.3%
Q2 24
49.8%
46.0%
Operating Margin
RGEN
RGEN
SAM
SAM
Q1 26
12.4%
Q4 25
9.0%
-8.6%
Q3 25
8.9%
11.5%
Q2 25
7.6%
14.0%
Q1 25
3.9%
7.4%
Q4 24
-17.7%
-13.9%
Q3 24
-5.1%
7.6%
Q2 24
1.0%
12.2%
Net Margin
RGEN
RGEN
SAM
SAM
Q1 26
Q4 25
6.7%
-5.8%
Q3 25
7.9%
8.6%
Q2 25
8.2%
10.3%
Q1 25
3.4%
5.4%
Q4 24
-17.4%
-9.6%
Q3 24
-0.4%
5.5%
Q2 24
2.2%
9.0%
EPS (diluted)
RGEN
RGEN
SAM
SAM
Q1 26
$2.16
Q4 25
$0.24
$-1.97
Q3 25
$0.26
$4.25
Q2 25
$0.26
$5.45
Q1 25
$0.10
$2.16
Q4 24
$-0.55
$-3.23
Q3 24
$-0.01
$2.86
Q2 24
$0.06
$4.39

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
RGEN
RGEN
SAM
SAM
Cash + ST InvestmentsLiquidity on hand
$767.6M
$164.1M
Total DebtLower is stronger
$542.2M
Stockholders' EquityBook value
$2.1B
$682.6M
Total Assets
$2.9B
$1.2B
Debt / EquityLower = less leverage
0.26×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
RGEN
RGEN
SAM
SAM
Q1 26
$164.1M
Q4 25
$767.6M
$223.4M
Q3 25
$748.7M
$250.5M
Q2 25
$708.9M
$212.4M
Q1 25
$697.2M
$152.5M
Q4 24
$757.4M
$211.8M
Q3 24
$784.0M
$255.6M
Q2 24
$809.1M
$219.3M
Total Debt
RGEN
RGEN
SAM
SAM
Q1 26
Q4 25
$542.2M
Q3 25
$537.9M
Q2 25
Q1 25
Q4 24
$525.6M
Q3 24
Q2 24
Stockholders' Equity
RGEN
RGEN
SAM
SAM
Q1 26
$682.6M
Q4 25
$2.1B
$846.3M
Q3 25
$2.1B
$911.0M
Q2 25
$2.1B
$912.3M
Q1 25
$2.0B
$897.0M
Q4 24
$2.0B
$916.2M
Q3 24
$2.0B
$1.0B
Q2 24
$2.0B
$1.0B
Total Assets
RGEN
RGEN
SAM
SAM
Q1 26
$1.2B
Q4 25
$2.9B
$1.2B
Q3 25
$2.9B
$1.2B
Q2 25
$2.9B
$1.3B
Q1 25
$2.9B
$1.2B
Q4 24
$2.8B
$1.3B
Q3 24
$2.8B
$1.4B
Q2 24
$2.9B
$1.4B
Debt / Equity
RGEN
RGEN
SAM
SAM
Q1 26
Q4 25
0.26×
Q3 25
0.26×
Q2 25
Q1 25
Q4 24
0.27×
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
RGEN
RGEN
SAM
SAM
Operating Cash FlowLast quarter
$25.7M
Free Cash FlowOCF − Capex
$17.6M
FCF MarginFCF / Revenue
8.9%
Capex IntensityCapex / Revenue
4.1%
Cash ConversionOCF / Net Profit
1.93×
TTM Free Cash FlowTrailing 4 quarters
$93.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
RGEN
RGEN
SAM
SAM
Q1 26
Q4 25
$25.7M
$39.9M
Q3 25
$48.1M
$101.8M
Q2 25
$28.6M
$126.5M
Q1 25
$15.0M
$1.9M
Q4 24
$39.2M
$41.9M
Q3 24
$49.3M
$115.9M
Q2 24
$42.2M
$96.0M
Free Cash Flow
RGEN
RGEN
SAM
SAM
Q1 26
Q4 25
$17.6M
$22.1M
Q3 25
$43.4M
$89.2M
Q2 25
$21.5M
$112.2M
Q1 25
$11.4M
$-8.0M
Q4 24
$33.6M
$18.4M
Q3 24
$42.3M
$99.2M
Q2 24
$37.4M
$75.6M
FCF Margin
RGEN
RGEN
SAM
SAM
Q1 26
Q4 25
8.9%
5.7%
Q3 25
23.0%
16.6%
Q2 25
11.8%
19.1%
Q1 25
6.8%
-1.8%
Q4 24
19.3%
4.6%
Q3 24
27.3%
16.4%
Q2 24
24.3%
13.1%
Capex Intensity
RGEN
RGEN
SAM
SAM
Q1 26
Q4 25
4.1%
4.6%
Q3 25
2.5%
2.3%
Q2 25
3.9%
2.4%
Q1 25
2.1%
2.2%
Q4 24
3.2%
5.8%
Q3 24
4.5%
2.8%
Q2 24
3.1%
3.5%
Cash Conversion
RGEN
RGEN
SAM
SAM
Q1 26
Q4 25
1.93×
Q3 25
3.23×
2.21×
Q2 25
1.92×
2.09×
Q1 25
2.57×
0.08×
Q4 24
Q3 24
3.46×
Q2 24
12.70×
1.83×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons